Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rock

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
The Journal of Biological Chemistry|February 1, 2022
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACsNan Bai, Kristin M Riching, Aman Makaju, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood SpotsKatherine Berman, Greta Van Slyke, Hayley Novak, et al.
The Journal of Infectious Diseases|July 19, 2003
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parametersMark Dybul, Elizabeth Nies-Kraske, Marybeth Daucher, et al.
Nature Microbiology|May 31, 2022
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosisShuqi Li, Nicholas C Poulton, Jesseon S Chang, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Journal of Medicinal Chemistry|October 9, 1999
Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic propertiesL Y Hu, T R Ryder, M F Rafferty, et al.
Frontiers in Pharmacology|October 4, 2021
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in <i>N</i>-Oleoylglycine and <i>N</i>-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These MediatorsSamantha M Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, et al.
Journal of Medicinal Chemistry|July 30, 1999
4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonistZ L Zhou, S X Cai, E R Whittemore, et al.
Drug Design and Discovery|August 6, 2000
Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activityL Y Hu, T R Ryder, M F Rafferty, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
The Journal of Biological Chemistry|February 1, 2022
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACsNan Bai, Kristin M Riching, Aman Makaju, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood SpotsKatherine Berman, Greta Van Slyke, Hayley Novak, et al.
The Journal of Infectious Diseases|July 19, 2003
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parametersMark Dybul, Elizabeth Nies-Kraske, Marybeth Daucher, et al.
Nature Microbiology|May 31, 2022
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosisShuqi Li, Nicholas C Poulton, Jesseon S Chang, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Journal of Medicinal Chemistry|October 9, 1999
Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic propertiesL Y Hu, T R Ryder, M F Rafferty, et al.
Frontiers in Pharmacology|October 4, 2021
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in <i>N</i>-Oleoylglycine and <i>N</i>-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These MediatorsSamantha M Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, et al.
Journal of Medicinal Chemistry|July 30, 1999
4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonistZ L Zhou, S X Cai, E R Whittemore, et al.
Drug Design and Discovery|August 6, 2000
Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activityL Y Hu, T R Ryder, M F Rafferty, et al.
Pageof 28